2 results
Approved WMOCompleted
Comparison of adenosine infusion and bolus injection of regadenoson for induction of maximum coronary hyperemia.
Approved WMORecruiting
The primary objective of the study is to demonstrate that lenvatinib in combination with everolimus (Arm A) or pembrolizumab (Arm B) is superior compared to sunitinib alone (Arm C) in improving progressionfree survival (PFS) (by independent imaging…